Even as the country is in the middle of a military action against terrorists network across the border, markets witnessed gyration during intra-day trades but eventually managed to shrug off the ...

Another application by Tesla to trademark the term "Robotaxi" for its upcoming ride-hailing service is still under examination by the office, the report said. The USPTO issued on Tuesday a ...

However, given ongoing geopolitical volatility, making the right technology investment decisions will be a key lever for business growth and competitive advantage. Forrester's (Nasdaq: FORR) research, ...

The Bangladesh Emerging team was formed mostly with the national players but they put a disappointing performance to dig the graveyards. Keep updated, follow The Business Standard's Google news ...

In thin trade amid holidays in some of the key Asian markets, including Japan and South Korea, Asian markets traded with modest gains. Singapore's Straits Times traded with a marginal cut, while Hong ...

This launch is part of Sunshine Biopharma’s efforts to expand its presence in Canada’s generic drugs market, which is projected to double from $9.4 billion to $19.2 billion by 2032. According to ...

Zeta Global (NYSE), the AI Marketing Cloud, today released the Zeta Economic Index (ZEI) for April 2025. Powered by Zeta's proprietary Generative AI technology and real-time consumer behavior from ...

Meanwhile, Hong Kong markets ... might impact the business. New manufacturing orders in Germany rose by 3.6% month on month on an adjusted basis, provisional data from the country's statistics ...

another leg down cannot be ruled out. There are lots of mixed signals, and therefore, the near-term trend is more important. The swing fell to 17 again, even as the market moved higher.

Alembic Pharmaceuticals on Friday said it has received approval from the US health regulator to market a generic medication for the prevention of heart attack and stroke. The company has received ...

The Supreme Court on Thursday stated that doctors nationwide should be required to prescribe only generic medicines instead of branded ones. The top court was hearing a Public Interest Litigation (PIL ...